Bone marrow transplantation from unrelated donors for genetic diseases following conditioning with Busulphan and Cyclophosphamide
Related Experiment Videos
Bone Marrow Transplantation
|January 1, 1991
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Afatinib plus gemcitabine versus gemcitabine alone as first-line treatment of metastatic pancreatic cancer: The randomised, open-label phase II ACCEPT study of the Arbeitsgemeinschaft Internistische Onkologie with an integrated analysis of the 'burden of therapy' method.
European journal of cancer (Oxford, England : 1990)·2021
Evaluation of impact of anti-idursulfase antibodies during long-term idursulfase enzyme replacement therapy in mucopolysaccharidosis II patients.
Molecular genetics and metabolism reports·2017
Response of 33 UK patients with infantile-onset Pompe disease to enzyme replacement therapy.
Journal of inherited metabolic disease·2015
Pre-transplant immunotherapy and MRD dynamics affect post-transplant prognosis in KMT2A-rearranged B-ALL patients.
Bone marrow transplantation·2026
How could calreticulin-targeting therapies change the myelofibrosis transplant paradigm?
Bone marrow transplantation·2026